Hepatitis B-C-D and Liver Cancer in Viet Nam:
Current Status and Future Directions – 2022
Website: VICLD Vietnam – First Vietnam International Conference on Liver Diseases
Link for online conference: https://bit.ly/webinar28072022
For offline guests: B701, 234 Pasteur, Ward 6, District 3, Ho Chi Minh City
Time: 9:00am – 6:00pm (Vietnam time GMT+7) 28/7/2022
Program Schedule
| Time | Title of Presentation | Speaker/Title | Affiliation | 
| 8:00-9:00 AM | Registration and Guest welcome and seating support | RCID | |
| 9:00-9:15 AM | Opening remarks by Prof. Vu Hai Quan, Dang Van Phuoc, Thao Nguyen, and Dr. Doan Dao | Intro by MC | |
| 9:15-9:20 AM | Intro speakers & panelists & distinguished guests
 Brief intro of the conference series & theme of the day program  | 
Intro by MC and Dr. Doan Dao
 
  | 
|
| 9:20-9:40 AM | Liver Cancer in Vietnam: Challenges in the Diagnosis, Treatment, and Surveillance | Huy S.D. Nguyen, MD
 Director  | 
Liver Tumor Department, Cho Ray Hospital, Vietnam | 
| 9:40-10:00 AM | A Multidisciplinary Approach and Experience in Liver Cancer Management at Johns Hopkins Hospital | Mark Yarchoan, MD
 Assistant Professor & Director  | 
Multidisciplinary Liver Cancer Clinic, JHU School of Medicine | 
| 10:00-10:20 AM | Potential Role of miRNA in Liver Cancer Diagnosis in Vietnam | Quoc Nguyen, PhD
 Associate Professor  | 
Nong Lam University, HCMC | 
| 10:20-10:50 AM | Tea-break | ||
| 10:50-11:10 AM | Biomarkers for the early detection and prognostication of liver cancer using big data analysis and machine learning | Nam Nguyen, PhD
 Research Professor  | 
Vietnam National University-HCMC, School of Medicine | 
| 11:10-11:30 AM | Living Donor Liver Transplantation in Developing Countries | Ahmet Gurakar, MD
 Professor & Director  | 
Liver Transplant Program, JHU School of Medicine | 
| 11:30 AM-12:30 PM | Panel discussion | ||
| 12:30-13:15 PM | Lunch on site | ||
| 13:35-13:55 PM | Global Initiatives for HBV-HCV-HDV Elimination | John Ward, MD
 Professor & Director  | 
Global Coalition for Hepatitis Elimination, The Global Task Force; Rollins School of Public Health, Emory University | 
| 13:55-14:15 PM | Global Implementation of Point of Care Rapid Tests for HBV-HCV Elimination | Homie Razavi, PhD
 Founder and Managing Director  | 
Center for Disease Analysis/Global Procurement Programs | 
| 14:15-14:35 PM | Is HBV Cure Within Reach? | Tim Block, PhD
 Professor & President  | 
Hepatitis B Foundation/Blumberg Research Institute/Pennsylvania Biotech Center | 
| 14:35-14:55 PM | Potential Long-Acting Treatments for HBV | David Thomas, MD, MPH
 Professor & Former Chief  | 
Division of Infectious Diseases, JHU School of Medicine | 
| 14:55-15:25 PM | Tea-break | ||
| 15:25-15:55 PM | Novel Therapy for HDV | Robert Gish, MD
 Professor & Medical Director  | 
Loma Linda School of Medicine/Hepatitis B Foundation | 
| 15:55-16:15 PM | HCV Micro-Elimination In HCMC: From Concept to Real-life Data to Elimination | Hong K. Tang, MD, PhD
 Associate Professor & Associate Dean  | 
Faculty of Public Health, Pham Ngoc Thach University of Medicine, HCMC | 
| 16:15-16:35 PM | Viral Hepatitis and Liver Cancer in HIV Population | Dung V. Do, MD, PhD
 Associate Professor & Dean  | 
School of Public Health, University of Medicine and Pharmacy-HCMC | 
| 16:35-17:30 PM | Panel discussion | ||
| 17:30-18:00 PM | Wrap up and closing
 Summarize lessons learned & propose solutions  | 
Panel chairs, organizers | 
Organizers: Johns Hopkins COE, VNU HCMC’s School of Medicine, and Research Center for Infectious Diseases
Organizing committee: Doan Dao, Phuoc Dang, Thao Nguyen, Hoai Nguyen, Diem Dao, Amy Trang, Hang Dao, Tuan Anh
Facebook: Vietnam Association for Research on Liver Diseases